- GE's (GE +1%) health unit has won FDA approval for a new artificial intelligence-powered X-ray device that reduces the time to diagnose and treat a collapsed lung from eight hours to as little as 15 minutes.
- The device, called the Critical Care Suite, uses AI algorithms to scan X-ray images and detect pneumothorax, which affects approximately 74K Americans each year.
- GE is also working to enhance the technology to detect other health conditions.
First FDA clearance for AI X-ray system
Recommended For You
About GE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
GE | - | - |
General Electric Company |